Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024 Nicholas Sosiak, CFO, will conduct a presentation that will cover key financial and operational results for the fiscal year ended Auguust 31 2024.

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded production.

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024 Cannara Biotech announces record-breaking July revenues and schedules an investor webcast for August 20, 2024. Join at 2 PM ET for Q3 updates and a live QA